Works matching IS 09509232 AND DT 2015 AND VI 34 AND IP 4

Results: 14

A link between inflammation and metastasis: serum amyloid A1 and A3 induce metastasis, and are targets of metastasis-inducing S100A4.

Published in:

Oncogene, 2015, v. 34, n. 4, p. 424, doi. 10.1038/onc.2013.568

By:

Hansen, M T;
Forst, B;
Cremers, N;
Quagliata, L;
Ambartsumian, N;
Grum-Schwensen, B;
Klingelhöfer, J;
Abdul-Al, A;
Herrmann, P;
Osterland, M;
Stein, U;
Nielsen, G H;
Scherer, P E;
Lukanidin, E;
Sleeman, J P;
Grigorian, M

Publication type:

Article

Loss of epithelial p53 and αv integrin cooperate through Akt to induce squamous cell carcinoma yet prevent remodeling of the tumor microenvironment.

Published in:

Oncogene, 2015, v. 34, n. 4, p. 516, doi. 10.1038/onc.2013.585

By:

Savar, A;
Acin, S;
Gonzalez, C L;
El-Sawy, T;
Mejia, O;
Li, Z;
Esmaeli, B;
Lacy-Hulbert, A;
El-Naggar, A K;
McCarty, J H;
Caulin, C

Publication type:

Article

Inhibition of ANKRD1 sensitizes human ovarian cancer cells to endoplasmic reticulum stress-induced apoptosis.

Published in:

Oncogene, 2015, v. 34, n. 4, p. 485, doi. 10.1038/onc.2013.566

By:

Lei, Y;
Henderson, B R;
Emmanuel, C;
Harnett, P R;
deFazio, A

Publication type:

Article

Transcriptional regulation of fibronectin by p21-activated kinase-1 modulates pancreatic tumorigenesis.

Published in:

Oncogene, 2015, v. 34, n. 4, p. 455, doi. 10.1038/onc.2013.576

By:

Jagadeeshan, S;
Krishnamoorthy, Y R;
Singhal, M;
Subramanian, A;
Mavuluri, J;
Lakshmi, A;
Roshini, A;
Baskar, G;
Ravi, M;
Joseph, L D;
Sadasivan, K;
Krishnan, A;
Nair, A S;
Venkatraman, G;
Rayala, S K

Publication type:

Article

KSHV vCyclin counters the senescence/G1 arrest response triggered by NF-κB hyperactivation.

Published in:

Oncogene, 2015, v. 34, n. 4, p. 496, doi. 10.1038/onc.2013.567

By:

Zhi, H;
Zahoor, M A;
Shudofsky, A M D;
Giam, C-Z

Publication type:

Article

Oncogenic Y641 mutations in EZH2 prevent Jak2/β-TrCP-mediated degradation.

Published in:

Oncogene, 2015, v. 34, n. 4, p. 445, doi. 10.1038/onc.2013.571

By:

Sahasrabuddhe, A A;
Chen, X;
Chung, F;
Velusamy, T;
Lim, M S;
Elenitoba-Johnson, K S J

Publication type:

Article

Casein kinase 1 regulates Sprouty2 in FGF-ERK signaling.

Published in:

Oncogene, 2015, v. 34, n. 4, p. 474, doi. 10.1038/onc.2013.564

By:

Yim, D G R;
Ghosh, S;
Guy, G R;
Virshup, D M

Publication type:

Article

Targeting RNA polymerase I to treat MYC-driven cancer.

Published in:

Oncogene, 2015, v. 34, n. 4, p. 403, doi. 10.1038/onc.2014.13

By:

Poortinga, G;
Quinn, L M;
Hannan, R D

Publication type:

Article

Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes.

Published in:

Oncogene, 2015, v. 34, n. 4, p. 506, doi. 10.1038/onc.2013.579

By:

Daniel, A R;
Gaviglio, A L;
Knutson, T P;
Ostrander, J H;
D'Assoro, A B;
Ravindranathan, P;
Peng, Y;
Raj, G V;
Yee, D;
Lange, C A

Publication type:

Article

TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis.

Published in:

Oncogene, 2015, v. 34, n. 4, p. 436, doi. 10.1038/onc.2013.569

By:

Cyr, A R;
Kulak, M V;
Park, J M;
Bogachek, M V;
Spanheimer, P M;
Woodfield, G W;
White-Baer, L S;
O'Malley, Y Q;
Sugg, S L;
Olivier, A K;
Zhang, W;
Domann, F E;
Weigel, R J

Publication type:

Article

SUPT6H controls estrogen receptor activity and cellular differentiation by multiple epigenomic mechanisms.

Published in:

Oncogene, 2015, v. 34, n. 4, p. 465, doi. 10.1038/onc.2013.558

By:

Bedi, U;
Scheel, A H;
Hennion, M;
Begus-Nahrmann, Y;
Rüschoff, J;
Johnsen, S A

Publication type:

Article

Growth factor receptor/steroid receptor cross talk in trastuzumab-treated breast cancer.

Published in:

Oncogene, 2015, v. 34, n. 4, p. 525, doi. 10.1038/onc.2013.586

By:

Collins, D C;
Cocchiglia, S;
Tibbitts, P;
Solon, G;
Bane, F T;
McBryan, J;
Treumann, A;
Eustace, A;
Hennessy, B;
Hill, A D;
Young, L S

Publication type:

Article

A chromatin modifier genetic screen identifies SIRT2 as a modulator of response to targeted therapies through the regulation of MEK kinase activity.

Published in:

Oncogene, 2015, v. 34, n. 4, p. 531, doi. 10.1038/onc.2013.588

By:

Bajpe, P K;
Prahallad, A;
Horlings, H;
Nagtegaal, I;
Beijersbergen, R;
Bernards, R

Publication type:

Article

MicroRNA-193a-3p and -5p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway.

Published in:

Oncogene, 2015, v. 34, n. 4, p. 413, doi. 10.1038/onc.2013.574

By:

Yu, T;
Li, J;
Yan, M;
Liu, L;
Lin, H;
Zhao, F;
Sun, L;
Zhang, Y;
Cui, Y;
Zhang, F;
He, X;
Yao, M

Publication type:

Article